October 17, 2017 6:47 PM ET


Company Overview of NovaBay Pharmaceuticals, Inc.

Executive Profile

Mark M. Sieczkarek M.B.A.

Chairman, Chief Executive Officer and President, NovaBay Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 organization across 5 different industries.

See Board Relationships
As of Fiscal Year 2016


Mr. Mark M. Sieczkarek, M.B.A., serves as the Chief Executive Officer of Fe3 Medical, Inc. Mr. Sieczkarek has been the Chief Executive Officer at NovaBay Pharmaceuticals, Inc. since June 3, 2016 and has been its President since June 13, 2016. He served as an Interim Chief Executive Officer and Interim President at NovaBay Pharmaceuticals, Inc from November 28, 2015 to June 3, 2016. He served as an Interim Chief Executive Officer and Interim President of Solta Medical, ...

Corporate Headquarters

2000 Powell Street
Emeryville, California 94608

United States

Phone: 510-899-8800
Fax: 510-474-1577

Board Members Memberships

Chairman, Chief Executive Officer and President


University at Buffalo
Canisius College

Other Affiliations

Annual Compensation

Total Annual Compensation$439,998

Stocks Options

All Other Compensation$13,500
Exercisable Options$21,312
Unexercisable Options$676,936
Total Number of Options$698,248

Total Compensation

Total Annual Cash Compensation$453,498
Total Short Term Compensation$439,998
Other Long Term Compensation$13,500
Total Calculated Compensation$2,004,096

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NovaBay Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.